|
|
Article: InvestSource: CepTor Finds Validation in the New England Journal of Medicine.
- Article from:
- M2 Presswire
- Article date:
- July 6, 2005
CopyrightCOPYRIGHT 2005 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-6 July 2005-InvestSource Inc.: InvestSource: CepTor Finds Validation in the New England Journal of Medicine(C)1994-2005 M2 COMMUNICATIONS LTD
RDATE:06072005
Stocks in the News: CepTor Corporation (Other OTC: CEPO), Omnicare Incorporated (NYSE: OCR), Armor Holdings Incorporated (NYSE: AH), Bausch & Lomb Incorporated (NYSE: BOL)
CepTor Corporation (Other OTC: CEPO) CEO William Pursley discussed recent events on the following webcast this past Monday, June 27. Among the items discusses was the June 9th article in the New England Journal of Medicine, "Mechanisms of Disease: Calpains and Disease." The article substantiates CepTor's drug ...